Metastatic Renal Cell Carcinoma
Showing 1 - 25 of 152
Metastatic Renal Cell Carcinoma, Brain Metastases Trial in United States (drug, device, radiation)
Recruiting
- Metastatic Renal Cell Carcinoma
- Brain Metastases
- Cabozantinib
- +2 more
-
Basking Ridge, New Jersey
- +6 more
Nov 10, 2023
Metastatic Renal Cell Carcinoma, Stage IV Renal Cell Cancer AJCC v8 Trial (Computed Tomography, Magnetic Resonance Imaging,
Not yet recruiting
- Metastatic Renal Cell Carcinoma
- Stage IV Renal Cell Cancer AJCC v8
- Computed Tomography
- +4 more
- (no location specified)
May 8, 2023
Learn About First and Later Lines of Medicines in Treating
Completed
- Metastatic Renal Cell Carcinoma
-
New York, New YorkPfizer Headquarters
May 12, 2023
Metastatic Renal Cell Carcinoma Trial in Shanghai (sunitinib or pazopanib, PD-1 inhibitor combined with axitinib)
Recruiting
- Metastatic Renal Cell Carcinoma
- sunitinib or pazopanib
- PD-1 inhibitor combined with axitinib
-
Shanghai, Shanghai, ChinaRenji Hospital, School of Medicine, Shanghai Jiao Tong Universit
Apr 16, 2023
Prostate Cancer, Breast Cancer, Kidney Cancer Trial in Tampere (behavioral, drug, other)
Not yet recruiting
- Prostate Cancer
- +11 more
- Guided physical exercise
- +2 more
-
Tampere, Länsi-Suomi, FinlandTampere University Hospital
Apr 3, 2023
Advanced Ovarian Carcinoma, Advanced Renal Cell Carcinoma, Advanced Pancreatic Carcinoma Trial in Bydgoszcz, Otwock, Warsaw
Recruiting
- Advanced Ovarian Carcinoma
- +7 more
-
Bydgoszcz, Kujawsko-pomorskie, Poland
- +2 more
Mar 7, 2023
Metastatic Renal Cell Carcinoma Trial in Cleveland (Nivolumab, Ipilimumab)
Active, not recruiting
- Metastatic Renal Cell Carcinoma
-
Cleveland, OhioCleveland Clinic Taussig Cancer Institute, Case Comprehensive Ca
Jan 25, 2023
Renal Cell Carcinoma, Metastatic Renal Cell Carcinoma, Kidney Cancer Trial in Boston (Implantable Microdevice (IMD))
Not yet recruiting
- Renal Cell Carcinoma
- +2 more
- Implantable Microdevice (IMD)
-
Boston, MassachusettsDana-Farber Cancer Institute
Jan 17, 2023
Metastatic Kidney Medullary Carcinoma, Metastatic Renal Cell Carcinoma, SMARCB1 Negative Trial in Houston (Doxorubicin,
Recruiting
- Metastatic Kidney Medullary Carcinoma
- +4 more
- Doxorubicin
- +5 more
-
Houston, TexasM D Anderson Cancer Center
Jan 20, 2023
Anatomic Stage IV Breast Cancer AJCC v8, Metastatic Breast Carcinoma, Metastatic Digestive System Carcinoma Trial in United
Recruiting
- Anatomic Stage IV Breast Cancer AJCC v8
- +12 more
- Memantine
- +4 more
-
Tucson, Arizona
- +60 more
Jan 11, 2023
Immunophenotyping in Metastatic Kidney Cancer Patients Receiving
Recruiting
- Metastatic Renal Cell Carcinoma
- Stage IV Renal Cell Cancer AJCC v8
- Biospecimen Collection
-
Rochester, MinnesotaMayo Clinic in Rochester
Jan 6, 2023
Clinical Stage IV Cutaneous Melanoma AJCC v8, Metastatic Colorectal Carcinoma, Metastatic Malignant Solid Tumor Trial in Canada,
Active, not recruiting
- Clinical Stage IV Cutaneous Melanoma AJCC v8
- +20 more
- Pembrolizumab
- Ziv-Aflibercept
-
Tampa, Florida
- +8 more
Jan 3, 2023
Advanced Clear Cell Renal Cell Carcinoma, Infiltrating Bladder Urothelial Carcinoma, Plasmacytoid Variant, Infiltrating Bladder
Active, not recruiting
- Advanced Clear Cell Renal Cell Carcinoma
- +35 more
- Cabozantinib S-malate
- +2 more
-
Duarte, California
- +7 more
Jan 3, 2023
Metastatic Renal Cell Carcinoma, Sarcomatoid Renal Cell Carcinoma, Stage II Renal Cell Cancer AJCC v7 Trial in Canada, Israel,
Active, not recruiting
- Metastatic Renal Cell Carcinoma
- +4 more
- Nephrectomy
- +4 more
-
Birmingham, Alabama
- +414 more
Dec 30, 2022
Advanced Malignant Solid Tumor, Clinical Stage III Cutaneous Melanoma AJCC v8, Clinical Stage IV Cutaneous Melanoma AJCC v8
Recruiting
- Advanced Malignant Solid Neoplasm
- +28 more
- Capecitabine
- +16 more
-
Conroe, Texas
- +4 more
Dec 5, 2022
Advanced Clear Cell Renal Cell Carcinoma, Advanced Papillary Renal Cell Carcinoma, Advanced Renal Cell Carcinoma Trial in Duarte
Recruiting
- Advanced Clear Cell Renal Cell Carcinoma
- +11 more
- Cabozantinib S-malate
- +2 more
-
Duarte, CaliforniaCity of Hope Medical Center
Nov 22, 2022
ccRCC, Clear Cell Renal Cell Carcinoma, Kidney Cancer Trial in United States (Oral NKT2152)
Recruiting
- ccRCC
- +9 more
- Oral NKT2152
-
Scottsdale, Arizona
- +6 more
Oct 17, 2022
Advanced Renal Cell Carcinoma, Clear Cell Renal Cell Carcinoma, Metastatic Renal Cell Carcinoma Trial in Duarte (Clostridium
Active, not recruiting
- Advanced Renal Cell Carcinoma
- +5 more
- Clostridium butyricum CBM 588 Probiotic Strain
- +2 more
-
Duarte, CaliforniaCity of Hope Medical Center
Oct 12, 2022
Database to prospectivelY aSSEss Changing TherapY Landscape in
Recruiting
- Metastatic Renal Cell Carcinoma
-
Iowa City, Iowa
- +7 more
Oct 13, 2022
Metastatic Renal Cell Carcinoma, Renal Cell Carcinoma Associated With Xp11.2 Translocations/TFE3 Gene Fusions, Stage III Renal
Recruiting
- Metastatic Renal Cell Carcinoma
- +4 more
- Axitinib
- Nivolumab
-
Birmingham, Alabama
- +255 more
Aug 24, 2022
Metastatic Renal Cell Carcinoma Trial in United Kingdom (Cyclophosphamide 50mg, Pembrolizumab 25 mg/1 ML Intravenous Solution
Recruiting
- Metastatic Renal Cell Carcinoma
- Cyclophosphamide 50mg
- Pembrolizumab 25 mg/1 ML Intravenous Solution [KEYTRUDA]
-
Cambridge, United Kingdom
- +3 more
Aug 22, 2022
Metastatic Melanoma, Advanced Locoregional Melanoma, Metastatic Renal Cell Carcinoma Trial run by the National Cancer Institute
Recruiting
- Metastatic Melanoma
- +3 more
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Aug 20, 2022